January 31, 2026 State Recommendations for Routine Childhood Vaccines: Increasing Departure from Federal Guidelines
January 31, 2026 Adjuvant Nivolumab Improves Disease-Free Survival in High-Risk Resected Head and Neck Squamous Cell Carcinoma
